Page last updated: 2024-09-04

bz-423 and Leukemia, Myeloid, Acute

bz-423 has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altucci, L; Balliu, M; Carafa, V; Cellai, C; Guandalini, L; Laurenzana, A; Matucci, R; Miniati, D; Nebbioso, A; Paoletti, F; Romanelli, MN; Torre, E	1

Other Studies

1 other study(ies) available for bz-423 and Leukemia, Myeloid, Acute

Article	Year
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells. Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:8 Topics: Acetylation; Animals; Apoptosis; Benzodiazepines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Leukemia, Myeloid, Acute; Mice; Reactive Oxygen Species; Receptors, GABA-A; Toxicity Tests, Acute	2012

Article

Year

The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells.

Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:8

Topics: Acetylation; Animals; Apoptosis; Benzodiazepines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Leukemia, Myeloid, Acute; Mice; Reactive Oxygen Species; Receptors, GABA-A; Toxicity Tests, Acute

2012